You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TSHA Sale Disclosure
Nagendran Sukumar · SEC Form 4 · Filed Jul 10, 2026
Sale
Calculated transaction value
$1.25M
Nagendran Sukumar President And Head Of R&D
TSHA
Transaction date
Jul 10, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed same day
TSHA daily price context
Close on/before transaction
$6.34
Jul 10, 2026
First close after public filing
$5.38
Jul 13, 2026
30-day return after filing
+18.4%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200,000 shares @ $6.24
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001665124-26-000013
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.25M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Taysha Gene Therapies, Inc. TSHA Current | Sale | Jul 10, 2026 | $1.25M |